Research Articles
China aims to vaccinate 50 million people by the end of March, but coverage for foreigners has been inconsistent between...
New government policies have updated some of the below information. We're currenly working to update this article. In the...
On July 31, US-China Business Council (USCBC) President Craig Allen testified before the US-China Economic Security Review...
The 13th National People’s Congress (NPC) kicks-off in Beijing on March 5.
Convening just after trade negotiations were...
Draft amendments make some progress in strengthening China’s intellectual property rights (IPR) system, including by...
On September 7, the 13th National People’s Congress Standing Committee (NPCSC), China’s constitutional authority, released its...
China’s regulators recently released the first drug traceability proposal since China suspended its previous system in 2016...
The Shanghai Free Trade Zone (FTZ) Market Regulatory Authority (MRA) recently issued a penalty decision against a foreign...
China has implemented new rules setting requirements on the storage, use, and flow of scientific data. Although intended to...
US companies now have stronger recourse against Chinese businesses that claim Chinese law as a protection for unfair practices...
China’s National Development and Reform Commission (NDRC) recently announced its 2018 priorities for pricing investigations...
To assist companies as they plan for the year ahead, US-China Business Council staff compiled short summaries of the recent...
Chinese regulations on tendering and bidding practices published by the Ministry of Finance (MOF) in July are a promising sign...
Recently announced provincial reimbursement drug lists (PRDLs) provide possible new opportunities for US pharmaceutical...
A series of recent hospital reforms by the Chinese government are designed to standardize pricing and encourage investment in...
Four new policies under development may address a variety of lingering regulatory hurdles for foreign drug and device companies...
As China aims to expand nationwide health insurance, improve patient access to care, strengthen primary care, and deepen...
The Chinese healthcare sector, which accounted for 6 percent of the country’s GDP in 2016, is expected to capture a 10 percent...
Healthcare reform and a desire for universal healthcare are key components of the 13th Five-Year Plan and require commercial...
The PRC National People’s Congress concluded this month with the release of China’s 13th Five-Year Plan (FYP) on National...
This issue marks the first of a regular series of US-China Business Council (USCBC) reports analyzing key discussions and...
Hindered by redundancies in the approval process, problems securing suitable data for clinical trials, and disparities in the...
US and Chinese negotiators are gearing up for a busy quarter as they head into bilateral and multilateral trade and investment...